Literature DB >> 16389312

Toxin-induced models of Parkinson's disease.

Jordi Bové1, Delphine Prou, Céline Perier, Serge Przedborski.   

Abstract

Parkinson's disease (PD) is a common neurodegenerative disease that appears essentially as a sporadic condition. It results mainly from the death of dopaminergic neurons in the substantia nigra. PD etiology remains mysterious, whereas its pathogenesis begins to be understood as a multifactorial cascade of deleterious factors. Most insights into PD pathogenesis come from investigations performed in experimental models of PD, especially those produced by neurotoxins. Although a host of natural and synthetic molecules do exert deleterious effects on dopaminergic neurons, only a handful are used in living laboratory animals to recapitulate some of the hallmarks of PD. In this review, we discuss what we believe are the four most popular parkinsonian neurotoxins, namely 6-hydroxydopamine (6-OHDA), 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), rotenone, and paraquat. The main goal is to provide an updated summary of the main characteristics of each of these four neurotoxins. However, we also try to provide the reader with an idea about the various strengths and the weaknesses of these neurotoxic models.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16389312      PMCID: PMC1144492          DOI: 10.1602/neurorx.2.3.484

Source DB:  PubMed          Journal:  NeuroRx        ISSN: 1545-5343


  122 in total

1.  Carrier-mediated processes in blood--brain barrier penetration and neural uptake of paraquat.

Authors:  K Shimizu; K Ohtaki; K Matsubara; K Aoyama; T Uezono; O Saito; M Suno; K Ogawa; N Hayase; K Kimura; H Shiono
Journal:  Brain Res       Date:  2001-07-06       Impact factor: 3.252

2.  Functional coupling of PSST and ND1 subunits in NADH:ubiquinone oxidoreductase established by photoaffinity labeling.

Authors:  F Schuler; J E Casida
Journal:  Biochim Biophys Acta       Date:  2001-07-02

3.  Variable effects of chronic subcutaneous administration of rotenone on striatal histology.

Authors:  Chunni Zhu; Patrick Vourc'h; Pierre-Olivier Fernagut; Sheila M Fleming; Sanja Lacan; Cheryl D Dicarlo; Ronald L Seaman; Marie-Françoise Chesselet
Journal:  J Comp Neurol       Date:  2004-10-25       Impact factor: 3.215

Review 4.  MPTP as a mitochondrial neurotoxic model of Parkinson's disease.

Authors:  Serge Przedborski; Kim Tieu; Celine Perier; Miquel Vila
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

5.  Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum.

Authors:  Y He; S Appel; W Le
Journal:  Brain Res       Date:  2001-08-03       Impact factor: 3.252

Review 6.  Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease.

Authors:  D Blum; S Torch; N Lambeng; M Nissou; A L Benabid; R Sadoul; J M Verna
Journal:  Prog Neurobiol       Date:  2001-10       Impact factor: 11.685

7.  6-Hydroxy-dopamine induced degeneration of central monoamine neurons.

Authors:  U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1968-12       Impact factor: 4.432

8.  Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

Authors:  U Ungerstedt; G W Arbuthnott
Journal:  Brain Res       Date:  1970-12-18       Impact factor: 3.252

9.  Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra.

Authors:  R L Faull; R Laverty
Journal:  Exp Neurol       Date:  1969-03       Impact factor: 5.330

10.  A fetal risk factor for Parkinson's disease.

Authors:  Brian K Barlow; Eric K Richfield; Deborah A Cory-Slechta; Mona Thiruchelvam
Journal:  Dev Neurosci       Date:  2004 Jan-Feb       Impact factor: 2.984

View more
  229 in total

1.  The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease.

Authors:  E Ilijic; J N Guzman; D J Surmeier
Journal:  Neurobiol Dis       Date:  2011-04-16       Impact factor: 5.996

Review 2.  Parkinson's disease: a rethink of rodent models.

Authors:  Heather L Melrose; Sarah J Lincoln; Glenn M Tyndall; Matthew J Farrer
Journal:  Exp Brain Res       Date:  2006-04-26       Impact factor: 1.972

Review 3.  Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.

Authors:  Sharawan Yadav; Anubhuti Dixit; Sonal Agrawal; Ashish Singh; Garima Srivastava; Anand Kumar Singh; Pramod Kumar Srivastava; Om Prakash; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2012-06-27       Impact factor: 5.590

4.  Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.

Authors:  Hironori Yokoyama; Ryohei Yano; Hayato Kuroiwa; Tatsuya Tsukada; Hiroto Uchida; Hiroyuki Kato; Jiro Kasahara; Tsutomu Araki
Journal:  Metab Brain Dis       Date:  2010-04-28       Impact factor: 3.584

5.  Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease.

Authors:  Eleni Antzoulatos; Michael W Jakowec; Giselle M Petzinger; Ruth I Wood
Journal:  Pharmacol Biochem Behav       Date:  2010-03-27       Impact factor: 3.533

Review 6.  Role of glial cells in neurotoxin-induced animal models of Parkinson's disease.

Authors:  Hironori Yokoyama; Hiroto Uchida; Hayato Kuroiwa; Jiro Kasahara; Tsutomu Araki
Journal:  Neurol Sci       Date:  2010-11-24       Impact factor: 3.307

Review 7.  Genetically engineered mouse models of Parkinson's disease.

Authors:  Donna M Crabtree; Jianhua Zhang
Journal:  Brain Res Bull       Date:  2011-08-03       Impact factor: 4.077

8.  Capsaicin Protects Against Oxidative Insults and Alleviates Behavioral Deficits in Rats with 6-OHDA-Induced Parkinson's Disease via Activation of TRPV1.

Authors:  ZhenXiang Zhao; JianFeng Wang; LingLing Wang; XiaoMei Yao; YiLin Liu; Ye Li; Si Chen; Tao Yue; XiaoTang Wang; WenFei Yu; YiMing Liu
Journal:  Neurochem Res       Date:  2017-08-31       Impact factor: 3.996

9.  ER Stress Induced by Tunicamycin Triggers α-Synuclein Oligomerization, Dopaminergic Neurons Death and Locomotor Impairment: a New Model of Parkinson's Disease.

Authors:  Valentín Cóppola-Segovia; Clarissa Cavarsan; Flavia G Maia; Anete C Ferraz; Lia S Nakao; Marcelo Ms Lima; Silvio M Zanata
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

10.  Aberrant regulation of choline metabolism by mitochondrial electron transport system inhibition in neuroblastoma cells.

Authors:  Ahmet T Baykal; Mohit R Jain; Hong Li
Journal:  Metabolomics       Date:  2008-12-01       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.